Skip to content

Welcome

Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

AAOA Member Benefits

  • Up to 60% discount for CME programs and free Annual Meeting. All AAOA’s CME programs meet ABOTOHNS Continuing Certification.
  • AAOA US ENT Affinity program, where AAOA members can gain savings on antigen, allergy supplies, and any of the other 5 service lines US ENT offers. For more email info@usentpartners.com.
  • Tools and resources to comply with US General Chapter 797 and practice management tools.
  • Advocacy support.
  • And much more! Learn More

PRACTICE MANAGEMENT CORNER

As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More

ADVOCACY UPDATES

Upcoming Dates

08/02/24: Scientific Abstract Submission Deadline
Learn more

12/01/24: Research Grant Cycle
Learn more

04/01/25: Fellow Exam Application Deadline
Learn more

06/01/25: Research Grant Cycle
Learn more

EDUCATION

AAOA Annual Meeting

Register for FREE* to attend the 2024 AAOA Annual Meeting in-person, in Las Vegas, or virtually!

*The 2024 AAOA Annual Meeting is FREE to all AAOA members in good standing

RESIDENTS

For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More and Register 

Coming Soon! New Explorers Course — Hybrid
90-days Access Feb 27 – May 27, 2025 
March 27-29, 2025 - Live
The Hythe, Vail, CO
Book Your Room

2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Book Your Room

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Available Now!

News and Updates

A Message from AAOA President, Alpen Patel, MD

Alpen Patel, MD, FAAOA is currently serving as 2019-2020 AAOA President. https://www.youtube.com/watch?v=WGGN1HewAsI AAOA's 2019-2020 President,…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

AAOA Logo

Scientific Abstracts Submissions Now Open

2024 AAOA Annual Meeting

computer-1149148_640

Submit Your Research

Have novel research tied to allergy, inflammatory disease in ENT, comprehensive management of allergy and inflammatory disease, or another aspect impacting ENT patient care?  AAOA is currently soliciting research abstracts for consideration for the 2024 Hybrid Annual Meeting

Accepted abstracts will cover the latest research tied to the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery related topics. These abstracts will be available as Scientific Research video presentations and hosted on the Whova platform, AAOA’s official meeting platform, for access by in-person and virtual attendees alike. The Scientific Research videos will be made available before and during the live component of the meeting. 

All 2024 Scientific Research Presentations will also be featured in a live Research Forum session at the Annual Meeting in Las Vegas. The PI/Presenter will be given a unique opportunity to showcase their research and results. Additionally, PI/Presenters will have access to the full AAOA 2024 Annual Meeting and will be able to claim CME/MOC credits. Below is an overview of the submission process. All abstracts will be peer-reviewed and must be novel research. 

Click here to submit a scientific abstract for the 2024 AAOA Annual Meeting.

Timeline:

  • 8/2 – Scientific abstract submission deadline (11:59 PM EST).
  • 9/2 – AAOA staff will notify the principal abstract authors of the outcome of their submission and share further instructions if selected.

If selected:

  • 10/1 – Video presentations are due along with the optional handouts for COI and content review.
  • 11/8 – 11/10 – 2024 AAOA Annual Meeting held live in Las Vegas and virtually.
  • 12/31 – Resulting manuscripts must be submitted to the International Forum of Allergy and Rhinology (IFAR), official journal of the AAOA.

Scientific Abstract Submission Format:

The scientific abstract submission form is broken down into the following sections:

  • Abstract title information
  • Author(s) and presenters’ information
  • Abstract content – Background, Methods, Results, Conclusions, and Author(s) Disclosures
    • Abstracts are limited to 3,000 characters

The author will receive an email confirmation of a successful submission.

Requirements:

  • Submission of an abstract for considerations infers ability to present in-person.

Selection of an abstract by the program committee will result in an invitation to the PI to attend in-person and participate in the 2024 Annual Meeting.

  • If the PI is unavailable to participate in the Annual Meeting, a corresponding author may be chosen to fill in. Please note, only 1 corresponding presenter may participate.
  • If the abstract is chosen, the PI/Presenter will need to register for the 2024 AAOA Annual Meeting, which is free for AAOA members. 
  • The pre-recorded video presentations will be showcased in our live Research Forum session at the Annual Meeting in Las Vegas.  An accompanying handout is encouraged to be submitted in addition to the video presentation as supporting content to share with the attendees but is not required.
  • Abstracts selected for scientific presentation must submit an accompanying manuscript to the official journal of the AAOA, International Forum of Allergy and Rhinology (IFAR), which will have the right of first refusal for the submitted manuscript. The manuscript submission deadline for the 2024 AAOA Annual Meeting is 11:59pm ET on December 31, 2024.
  • All off-label or non-FDA approved uses must be disclosed. Failure to comply with the abstract submission requirements may result in automatic withdrawal of the abstract for consideration by the program committee and possible suspension from future meeting presentations.
  • Presentations submitted or presented by or on behalf of an employee of an ACCME-defined ineligible company will not be considered if there is a conflict of interest between the content presented and the author(s) or presenter. 
  • Any funding associated with the research must be disclosed, along with the conflict of interest disclosures for the PI and co-authors.
  • Accepted abstracts presented outside of the AAOA must disclose that the data has been presented to AAOA and submitted to IFAR.

For any questions regarding the abstract submission/format, requirements, and more, please email us at meetings@aaoallergy.org.

Embargo Policy:


Accepted abstracts are made available to meeting attendees online in advance of the meeting via the pre-recorded abstract video presentations. Information contained in those abstracts may not be released until the abstracts appear online and is under embargo until October 21, 2024. Media, corporations, and institutions issuing press releases are required to abide by the embargo policies governing the AAOA’s annual meeting. 

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy.

Abstracts selected for scientific presentation are required to submit an accompanying manuscript to the official journal of the AAOA, International Forum of Allergy and Rhinology (IFAR), which will have the right of first refusal for the submitted manuscript. Once the manuscript is submitted, the author must abide by all IFAR publication criteria. 

If you have questions about the AAOA abstract embargo policy, please email meetings@aaoallergy.org.

FAQs:

Q: Are late breaking abstracts accepted?

A: We do not offer late breaking abstracts and only hold one call for abstracts, which has a deadline of August 2, 2024 at 11:59 PM ET.

 

Q: If my abstract is selected and I am only able to record and submit the video recording but cannot attend the Research Forum panel live, what should I do?

A: Please let AAOA staff know as soon as possible that you cannot attend live. You will need to designate a corresponding author who is able to attend live.

 

Q: Can I have a corresponding author record the abstract video?

A: Yes, that is fine.

 

Q: Who retains the copyright of the submitted and accepted abstract?

A: The AAOA retains the content presented for our meeting archives and re-use as we deem fit.

 

Q: Can my accepted abstract be presented again afterwards at other conferences?

A: Yes, the abstracts could be presented again as long as acknowledgment of the abstract being presented at our meeting and submitted as a manuscript to IFAR is given.

 

Q: Are encore abstracts accepted by the AAOA?

A: The AAOA does not accept encore abstract submissions and requires original presentations be submitted.

 

Q: There is only room for 5 authors on the submission form. If I have more than 5, how can I include them?

A: You can include the authors in the Content section. Please be sure to include their disclosures in the Author(s) disclosure section.

 

Q: Are tables and/or figures allowed on the submission form?

A: The submission form does not allow tables or images. This can be included in your video presentation, however.

Back To Top